Olanzapine for the prevention and treatment of chemotherapy-induced nausea and vomiting: a review to identify the best way to administer the drug
XL Zhang, JE Ying - Current Oncology, 2022 - mdpi.com
Common treatment methods for malignant tumors include surgery, chemotherapy,
radiotherapy, immunotherapy, targeted therapy, etc., among which chemotherapy plays an …
radiotherapy, immunotherapy, targeted therapy, etc., among which chemotherapy plays an …
Low-dose versus standard-dose olanzapine with triple antiemetic therapy for prevention of highly emetogenic chemotherapy-induced nausea and vomiting in patients …
J Bajpai, V Kapu, S Rath, S Kumar, A Sekar… - The Lancet …, 2024 - thelancet.com
Background Olanzapine is an effective antiemetic agent but it results in substantial daytime
somnolence when administered at the standard dose. Our aim was to compare the efficacy …
somnolence when administered at the standard dose. Our aim was to compare the efficacy …
Research trends on chemotherapy induced nausea and vomiting: a bibliometric analysis
C Ning, Y Yan, Y Wang, R Li, W Liu, L Qiu… - Frontiers in …, 2024 - frontiersin.org
Background CINV is a frequent adverse response to cancer treatment. There is still much to
learn about the pathophysiology and initiating event of CINV, which necessitates continued …
learn about the pathophysiology and initiating event of CINV, which necessitates continued …
Olanzapine within steroid-sparing antiemetic regimen to prevent chemotherapy-induced nausea and vomiting in patients with acute leukemia receiving multi-day …
G Hsu, C Bernhardi, J Lawson… - Journal of Oncology …, 2024 - journals.sagepub.com
Introduction Olanzapine use for chemotherapy-induced nausea and vomiting (CINV) in
hematological malignancies, for multi-day chemotherapy, and with a steroid-sparing …
hematological malignancies, for multi-day chemotherapy, and with a steroid-sparing …
Anti-Emetics in Children Receiving Chemotherapy for Solid Tumors and Leukemia: Pharmacology and Optimization of Therapy for Nausea and Vomiting
The management of chemotherapy-induced nausea and vomiting (CINV) in children
remains challenging due to differences in the chemotherapy regimens, their relative …
remains challenging due to differences in the chemotherapy regimens, their relative …
Reply to L. Celio et al.
H Minatogawa, N Izawa, TE Nakajima - British Journal of Cancer, 2024 - nature.com
Celio et al.[1] pointed out the difficulty of interpreting the significant increase in mild to
moderate nausea and appetite loss in the Dexamethasone (DEX)-sparing arm in the …
moderate nausea and appetite loss in the Dexamethasone (DEX)-sparing arm in the …
Dexamethasone-Free Antiemetic Prophylaxis for Highly Emetogenic Chemotherapy: A Double-Blind, Phase III Randomized Controlled Trial (CINV POD study)
V Radhakrishnan, K Venkatakrishnan… - JCO Global …, 2024 - ascopubs.org
PURPOSE The effectiveness of a dexamethasone (DEX)-free regimen for chemotherapy-
induced nausea and vomiting (CINV) prophylaxis in patients receiving highly emetogenic …
induced nausea and vomiting (CINV) prophylaxis in patients receiving highly emetogenic …
[HTML][HTML] Prevention and management of acute toxicities from conditioning regimens during hematopoietic stem cell transplantation
J Sawyer, T Elliott, L Orton, H Sowell… - Clinical Hematology …, 2024 - ncbi.nlm.nih.gov
Hematopoietic stem cell transplantation (HSCT) remains the only curative option for several
hematological malignancies. Its use has continued to grow, with an estimated 23,500 …
hematological malignancies. Its use has continued to grow, with an estimated 23,500 …
[PDF][PDF] Antiemetika-Vuxen
H Nilsson-Ehle, L Solitander, M Karlman - kunskapsbanken.cancercentrum.se
Ett av målen med denna sammanställning av antiemetika riktlinjer är att alla patienter med
cancersjukdom inom hematologi och onkologi som får intravenös cytostatikabehandling i …
cancersjukdom inom hematologi och onkologi som får intravenös cytostatikabehandling i …